Cargando…

3D-QSAR and Cell Wall Permeability of Antitubercular Nitroimidazoles against Mycobacterium tuberculosis

Inhibitory activities of monocyclic nitroimidazoles against Mycobacterium tuberculosis (Mtb) deazaflavin-dependent nitroreductase (DDN) were modeled by using docking, pharmacophore alignment and comparative molecular similarity indices analysis (CoMSIA) methods. A statistically significant model obt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang-Ho, Choi, Minsung, Kim, Pilho, Myung, Pyung Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270125/ https://www.ncbi.nlm.nih.gov/pubmed/24217328 http://dx.doi.org/10.3390/molecules181113870

Ejemplares similares

Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid
por: Thompson, Andrew M., et al.
Publicado: (2017)

Mesoporous Silica Nanoparticles Improve Oral Delivery of Antitubercular Bicyclic Nitroimidazoles
por: Ang, Chee Wei, et al.
Publicado: (2021)

Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering
por: Lee, Brendon M., et al.
Publicado: (2020)

Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
por: Makowska-Grzyska, Magdalena, et al.
Publicado: (2015)

Physicochemical properties and Mycobacterium tuberculosis transporters: keys to efficacious antitubercular drugs?
por: Fullam, Elizabeth, et al.
Publicado: (2020)

Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs
por: Lavin, Richard C., et al.
Publicado: (2021)

In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis
por: Shetye, Gauri S., et al.
Publicado: (2021)

Pharmacovigilance of Antitubercular Therapy in Tuberculosis
por: Ravichandran, Mirunalini, et al.
Publicado: (2022)

Synthesis, Biological Evaluation and 2D-QSAR Study of Halophenyl Bis-Hydrazones as Antimicrobial and Antitubercular Agents
por: Abdel-Aziz, Hatem A., et al.
Publicado: (2015)

Imaging latent tuberculosis infection with radiolabeled nitroimidazoles
por: Ankrah, Alfred O., et al.
Publicado: (2016)

Antitubercular evaluation of root extract and isolated phytochemicals from Lophira lanceolata against two resistant strains of Mycobacterium tuberculosis
por: Nkot, Jeanne Louise, et al.
Publicado: (2018)

Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India
por: Rao, Mahadev, et al.
Publicado: (2023)

Mycobacterium tuberculosis Cell Wall Permeability Model Generation Using Chemoinformatics and Machine Learning Approaches
por: Nagamani, Selvaraman, et al.
Publicado: (2021)

Chemosensitization by lipophilic nitroimidazoles.
por: Twentyman, P. R., et al.
Publicado: (1983)

Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents
por: Russo, Francesco, et al.
Publicado: (2015)

Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection
por: Kieswetter, Nathan S., et al.
Publicado: (2022)

Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs
por: De Socio, Giuseppe Vittorio, et al.
Publicado: (2012)

Antituberculars: Paradoxical worsening of pulmonary tuberculosis: case report
Publicado: (2020)

Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria
por: Zhuang, Zhijun, et al.
Publicado: (2020)

The Role of Nitroreductases in Resistance to Nitroimidazoles
por: Thomas, Carol, et al.
Publicado: (2021)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
por: Adeniji, Shola Elijah, et al.
Publicado: (2019)

Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
por: Lakshminarayana, Suresh B., et al.
Publicado: (2014)

Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle
por: Djemal, Saif Eddine, et al.
Publicado: (2018)

Clinical value of a whole blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection during antitubercular treatment
por: WANG, HAIFENG, et al.
Publicado: (2013)

S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope
por: Singh, Padam, et al.
Publicado: (2017)

Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria
por: Alahari, Anuradha, et al.
Publicado: (2007)

Development of QSAR models to predict blood-brain barrier permeability
por: Faramarzi, Sadegh, et al.
Publicado: (2022)

Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
por: Sheldon, P. W., et al.
Publicado: (1982)

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis
por: Van Bocxlaer, Katrien, et al.
Publicado: (2019)

QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis
por: Valencia, Jhesua, et al.
Publicado: (2022)

Proceedings of the Workshop on the Enhancement of Chemotherapy by Nitroimidazoles
Publicado: (1982)

Treatment of Giardiasis after Nonresponse to Nitroimidazole
por: Meltzer, Eyal, et al.
Publicado: (2014)

Core Shell Investigation of 2-nitroimidazole
por: Bolognesi, Paola, et al.
Publicado: (2019)

Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis
por: Ydsten, Karin A, et al.
Publicado: (2021)

1408. Epidemiology of Nitroimidazole-refractory Giardiasis
por: Ydsten, Karin, et al.
Publicado: (2023)

(68)Ga‐nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series
por: Bresser, Philippa L, et al.
Publicado: (2022)

Effect of antitubercular treatment on ovarian function in female genital tuberculosis with infertility
por: Sharma, Jai Bhagwan, et al.
Publicado: (2016)

Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
por: Singh, Padam, et al.
Publicado: (2017)

Investigating the Roles of Active Site Residues in Mycobacterium tuberculosis Indole-3-glycerol Phosphate Synthase, a Potential Target for Antitubercular Agents
por: Konas, David W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jfp1lrp487ip8gi27m9iv86e59